Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
for
Nausea and Vomiting, Obesity
Location: Tampa FL, San Diego CA, Los Angeles CA
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07446439
Phase 3, Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Tampa FL, Brandon FL, Wellington FL, Pembroke Pines FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase 2, Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
for
Primary Biliary Cholangitis (PBC)
Location: Tampa FL, Pembroke Pines FL, Miami FL, Charleston SC,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT06016842
Phase 3, Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
for
Growth Hormone Deficiency
Location: Tampa FL, Orlando FL, Sandy Springs GA, Columbia SC,
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Tampa FL, Savannah GA, Atlanta GA, Birmingham AL,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Tampa FL, Celebration FL, Gainesville FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase 1, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Tampa FL, Orlando FL, Jacksonville FL, Miami FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase 3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Tampa FL, Miami Lakes FL, Coral Gables FL, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06855160
Phase 3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Tampa FL, Raleigh NC, Houston TX, St Louis MO,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase 1, Recruiting
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Tampa FL, Buffalo NY
Sponsor: Celyad Oncology SA
Sex: All
Age: 18+
Code: NCT03018405
Phase 1, Phase 2, Recruiting
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Location: Tampa FL, Hickory NC, Nashville TN, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06952010
Phase 1, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations